(Q44776291)

6 December 2017

title

A Phase II study of docetaxel and carboplatin as neoadjuvant therapy for nasopharyngeal carcinoma with early T status and advanced N status (English)

1 reference

Vassiliki Papadimitrakopoulou

6 December 2017

1 reference

1 reference

9

object named as

Vassiliki Papadimitrakopoulou

1 reference

6 December 2017

2

Adam Garden

1 reference

6 December 2017

8

William Morrison

1 reference

6 December 2017

Faye M Johnson

1

1 reference

6 December 2017

J Lynn Palmer

3

1 reference

6 December 2017

Merrill Kies

4

1 reference

6 December 2017

Gary Clayman

5

1 reference

6 December 2017

Brenda Brumfield

6

1 reference

6 December 2017

Fadlo R Khuri

7

1 reference

6 December 2017

Eduardo M Diaz

10

1 reference

6 December 2017

Bonnie S Glisson

11

1 reference

6 December 2017

language of work or name

English

0 references

publication date

1 March 2004

1 reference

6 December 2017

1 reference

6 December 2017

volume

100

1 reference

6 December 2017

issue

5

1 reference

6 December 2017

page(s)

991-998

1 reference

Carcinoma of the nasopharynx treated by radiotherapy alone: determinants of distant metastasis and survival

6 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20079

7 January 2021

Analysis of 1379 patients with nasopharyngeal carcinoma treated by radiation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20079

7 January 2021

Does induction chemotherapy have a role in the management of nasopharyngeal carcinoma? Results of treatment in the era of computerized tomography

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20079

7 January 2021

Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20079

7 January 2021

A prospective randomized study of chemotherapy adjunctive to definitive radiotherapy in advanced nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20079

7 January 2021

Adjuvant chemotherapy with vincristine, cyclophosphamide, and doxorubicin after radiotherapy in local-regional nasopharyngeal cancer: results of a 4-year multicenter randomized study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20079

7 January 2021

Results of a prospective randomized trial comparing neoadjuvant chemotherapy plus radiotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20079

7 January 2021

Combined chemoradiation versus radiation therapy alone in locally advanced nasopharyngeal carcinoma: results of a meta-analysis of 1,528 patients from six randomized trials

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20079

7 January 2021

Induction chemotherapy followed by radiotherapy versus radiotherapy alone in patients with advanced nasopharyngeal carcinoma: results of a matched cohort study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20079

7 January 2021

Induction chemotherapy with mitomycin, epirubicin, cisplatin, fluorouracil, and leucovorin followed by radiotherapy in the treatment of locoregionally advanced nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20079

7 January 2021

Neoadjuvant chemotherapy and radiation therapy compared with radiation therapy alone in advanced nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20079

7 January 2021

Enhancement of local control in locally advanced node-positive nasopharyngeal carcinoma by adjunctive chemotherapy.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20079

7 January 2021

Effectiveness of combined induction chemotherapy and radiotherapy in advanced nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20079

7 January 2021

Patterns of failure after induction chemotherapy and radiotherapy for locoregionally advanced nasopharyngeal carcinoma: the Queen Mary Hospital experience

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20079

7 January 2021

A prospective, randomized trial comparing neoadjuvant chemotherapy with radiotherapy alone in patients with advanced nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20079

7 January 2021

Prediction of creatinine clearance from serum creatinine

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20079

7 January 2021

Carboplatin dosage: prospective evaluation of a simple formula based on renal function

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20079

7 January 2021

Docetaxel, cisplatin, and 5-fluorouracil-based induction chemotherapy in patients with locally advanced squamous cell carcinoma of the head and neck: the Dana Farber Cancer Institute experience

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20079

7 January 2021

Final report of a phase II evaluation of paclitaxel in patients with advanced squamous cell carcinoma of the head and neck: an Eastern Cooperative Oncology Group trial (PA390)

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20079

7 January 2021

Docetaxel: an active drug for squamous cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20079

7 January 2021

Activity of paclitaxel by three-hour infusion in Asian patients with metastatic undifferentiated nasopharyngeal cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20079

7 January 2021

Phase II trial of a paclitaxel and carboplatin combination in Asian patients with metastatic nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20079

7 January 2021

A phase II study of combination paclitaxel and carboplatin in advanced nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20079

7 January 2021

A randomized study of epirubicin monotherapy every four or every two weeks in advanced breast cancer. A Hellenic Cooperative Oncology Group study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20079

7 January 2021

A Phase II trial of docetaxel and cisplatin in patients with recurrent or metastatic nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20079

7 January 2021

Identifiers

DOI

10.1002/CNCR.20079

1 reference

6 December 2017

1 reference